The American College of Radiology (ACR) provided the White House with recommendations on regulating and monitoring AI technologies in clinical radiology.
Key Details
- 1ACR submitted feedback to the White House Office of Science and Technology Policy on AI integration in clinical settings.
- 2Key focus areas include AI oversight, reimbursement strategies, and government transparency.
- 3ACR stressed enhancing FDA oversight, especially for adaptive and continuous learning AI systems.
- 4They recommended real-world and post-market monitoring to address issues like AI model drift.
- 5ACR highlighted national AI registries such as Assess-AI for ongoing model performance tracking and data privacy concerns.
Why It Matters
These recommendations will help shape national policy around safe, effective, and transparent use of AI in radiology, directly impacting radiologists, vendors, and patients. Real-world tracking and better regulation are critical for trustworthy AI adoption in medical imaging.
Source
Radiology Business
Related News
•HealthExec
AI Reimbursement, Biomedical Research, and Exec Survey Highlight Healthcare Trends
Healthcare AI adoption is rising, but ROI measurement and clinical impact remain key challenges.
•HealthExec
Senate Vote Fails to Block AI Medicare Prior Authorization Pilot
A Senate vote failed to halt the WISeR AI-based prior authorization pilot for traditional Medicare claims.
•HealthExec
Mayo Clinic Sued Over Alleged AI Improprieties and Whistleblower Retaliation
A former Mayo Clinic research director sues the institution, alleging retaliation after raising concerns about improper AI use affecting patient safety and data integrity.